Literature DB >> 8275659

[Tauro-ursodeoxycholic acid vs. ursodeoxycholic acid in the dissolution of biliary calculi. Results of a single blind study].

V Gallo1, A G De Micheli, L Chiandussi.   

Abstract

Out of 34 patients enrolled and randomized, 31 completed the 6 months study period. Fifteen were treated with TUDCA, and 16 with UDCA. Dosage for both drugs was 10 mg/kg body weight daily. Superiprisingly, TUDCA was not found to be more active than UDCA in dissolving, totally or partially, the gallbladder stones; indeed, total dissolution was more frequent in the UDCA group. Since the two groups were similar as to number and size of the stones, the better results with UDCA cannot be attributed to the characteristics of the calculosis but must be ascribed to the molecule used. Both drugs induced an improvement in dyspeptic symptoms, but from this point of view, too, UCDA was more effective than TUDCA (p < 0.01). Finally, tolerability was also significantly better for UDCA, although TUDCA was altogether acceptable.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8275659

Source DB:  PubMed          Journal:  Clin Ter        ISSN: 0009-9074


  2 in total

1.  Preparation and toxicity evaluation of a novel nattokinase-tauroursodeoxycholate complex.

Authors:  Rui Feng; Jing Li; Jiepeng Chen; Lili Duan; XinRong Liu; Donghua Di; Yihui Deng; Yanzhi Song
Journal:  Asian J Pharm Sci       Date:  2017-11-10       Impact factor: 6.598

Review 2.  Bile acids for viral hepatitis.

Authors:  W Chen; J Liu; C Gluud
Journal:  Cochrane Database Syst Rev       Date:  2007-10-17
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.